$1.21 Billion is the total value of NEA Management Company, LLC's 46 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 4.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALLK | ALLAKOS INC | $178,348,000 | +81.5% | 2,268,188 | 0.0% | 14.77% | +114.5% | |
| RARX | RA PHARMACEUTICALS INC | $145,183,000 | -21.4% | 6,138,797 | 0.0% | 12.02% | -7.0% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $106,057,000 | -1.9% | 4,912,306 | 0.0% | 8.78% | +16.0% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $85,697,000 | -13.0% | 2,090,678 | 0.0% | 7.10% | +2.9% | |
| NET | New | CLOUDFLARE INC | $75,383,000 | – | 4,059,376 | +100.0% | 6.24% | – |
| ARDX | ARDELYX INC | $72,075,000 | +74.7% | 15,335,047 | 0.0% | 5.97% | +106.5% | |
| EPZM | EPIZYME INC | $45,154,000 | -17.8% | 4,377,518 | 0.0% | 3.74% | -2.9% | |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $42,129,000 | – | 4,187,801 | +100.0% | 3.49% | – |
| GLYC | GLYCOMIMETICS INC | $39,174,000 | -63.8% | 9,089,041 | 0.0% | 3.24% | -57.3% | |
| OBSV | OBSEVA SA | $38,206,000 | -26.3% | 4,586,563 | 0.0% | 3.16% | -13.0% | |
| SENS | SENSEONICS HOLDINGS INC | $30,579,000 | -51.5% | 30,888,266 | 0.0% | 2.53% | -42.6% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $27,704,000 | -68.2% | 6,643,704 | 0.0% | 2.29% | -62.4% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $27,622,000 | -18.8% | 5,172,683 | 0.0% | 2.29% | -4.1% | |
| MRKR | MARKER THERAPEUTICS INC | $25,550,000 | -35.5% | 5,000,000 | 0.0% | 2.12% | -23.8% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $23,907,000 | -62.4% | 15,832,611 | 0.0% | 1.98% | -55.6% | |
| DERM | DERMIRA INC | $22,407,000 | -33.2% | 3,506,649 | 0.0% | 1.86% | -21.0% | |
| AVEO | AVEO PHARMACEUTICALS INC | $21,318,000 | +26.0% | 25,243,865 | 0.0% | 1.76% | +48.9% | |
| GNCA | GENOCEA BIOSCIENCES INC | $20,954,000 | -26.0% | 7,225,676 | 0.0% | 1.74% | -12.6% | |
| TRVI | Buy | TREVI THERAPEUTICS INC | $19,986,000 | -39.8% | 4,441,360 | +0.3% | 1.66% | -28.9% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $18,903,000 | -60.8% | 11,963,649 | +0.6% | 1.56% | -53.6% |
| AFMD | AFFIMED NV | $15,108,000 | +2.4% | 5,138,888 | 0.0% | 1.25% | +21.1% | |
| MLND | MILLENDO THERAPEUTICS INC | $12,562,000 | -38.5% | 1,766,779 | 0.0% | 1.04% | -27.3% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $9,898,000 | -23.6% | 4,141,308 | 0.0% | 0.82% | -9.7% | |
| SYBX | SYNLOGIC INC | $9,685,000 | -74.8% | 4,229,410 | 0.0% | 0.80% | -70.3% | |
| MEIP | MEI PHARMA INC | $9,611,000 | -32.8% | 5,720,572 | 0.0% | 0.80% | -20.6% | |
| LQDA | LIQUIDIA TECHNOLOGIES INC | $8,850,000 | -55.5% | 2,486,062 | 0.0% | 0.73% | -47.4% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $8,828,000 | -27.8% | 1,562,500 | 0.0% | 0.73% | -14.7% | |
| DZSI | DASAN ZHONE SOLUTIONS INC | $8,759,000 | -29.5% | 956,255 | 0.0% | 0.72% | -16.7% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $7,171,000 | -52.1% | 2,382,286 | 0.0% | 0.59% | -43.4% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $6,065,000 | -28.4% | 3,243,150 | 0.0% | 0.50% | -15.3% | |
| VRNA | VERONA PHARMA PLCads | $5,574,000 | -10.4% | 1,219,674 | 0.0% | 0.46% | +6.0% | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $5,430,000 | +201.3% | 602,663 | +229.8% | 0.45% | +257.1% |
| SURF | SURFACE ONCOLOGY INC | $4,708,000 | -49.6% | 3,315,149 | 0.0% | 0.39% | -40.5% | |
| PTI | PROTEOSTASIS THERAPEUTICS INC | $4,695,000 | -13.3% | 5,556,778 | 0.0% | 0.39% | +2.4% | |
| BE | BLOOM ENERGY CORP | $4,333,000 | -73.5% | 1,333,333 | 0.0% | 0.36% | -68.7% | |
| XFOR | X4 PHARMACEUTICALS INC | $4,237,000 | -15.3% | 333,333 | 0.0% | 0.35% | +0.3% | |
| TRVN | TREVENA INC | $3,687,000 | -6.1% | 3,811,691 | 0.0% | 0.30% | +10.9% | |
| CTIC | CTI BIOPHARMA CORP | $3,139,000 | -2.6% | 3,750,000 | 0.0% | 0.26% | +15.0% | |
| ERYP | ERYTECH PHARMA SAadr | $2,644,000 | -40.8% | 625,000 | 0.0% | 0.22% | -30.0% | |
| TCON | TRACON PHARMACEUTICALS INC | $1,550,000 | -34.3% | 3,467,181 | 0.0% | 0.13% | -22.4% | |
| RGLS | REGULUS THERAPEUTICS INC | $1,478,000 | -42.4% | 2,052,455 | 0.0% | 0.12% | -32.2% | |
| ELGX | ENDOLOGIX INC | $989,000 | -45.1% | 249,021 | 0.0% | 0.08% | -34.9% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $935,000 | -0.8% | 1,298,274 | 0.0% | 0.08% | +16.7% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $773,000 | -15.3% | 452,167 | 0.0% | 0.06% | 0.0% | |
| TRILLIUM THERAPEUTICS INC | $646,000 | -6.5% | 2,100,000 | 0.0% | 0.05% | +10.4% | ||
| AKAOQ | ACHAOGEN INC | $63,000 | -36.4% | 5,215,128 | 0.0% | 0.01% | -28.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-10-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.